Risk JM - Search Results

1

Prediction of malignant transformation in oral epithelial dysplasia using infrared absorbance spectra.

Ellis BG, Whitley CA, Triantafyllou A, Gunning PJ, Smith CI, Barrett SD, Gardner P, Shaw RJ, Weightman P, Risk JM. Ellis BG, et al. Among authors: risk jm. PLoS One. 2022 Mar 25;17(3):e0266043. doi: 10.1371/journal.pone.0266043. eCollection 2022. PLoS One. 2022. PMID: 35333891 Free PMC article.

2

Monitoring of circulating tumour-associated DNA as a prognostic tool for oral squamous cell carcinoma.

Thomas E, Shaw RJ, Risk JM. Thomas E, et al. Among authors: risk jm. Br J Cancer. 2005 Oct 17;93(8):960. doi: 10.1038/sj.bjc.6602801. Br J Cancer. 2005. PMID: 16205697 Free PMC article. No abstract available.

3

Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing.

Shaw RJ, Liloglou T, Rogers SN, Brown JS, Vaughan ED, Lowe D, Field JK, Risk JM. Shaw RJ, et al. Among authors: risk jm. Br J Cancer. 2006 Feb 27;94(4):561-8. doi: 10.1038/sj.bjc.6602972. Br J Cancer. 2006. PMID: 16449996 Free PMC article.

4

Methylation enrichment pyrosequencing: combining the specificity of MSP with validation by pyrosequencing.

Shaw RJ, Akufo-Tetteh EK, Risk JM, Field JK, Liloglou T. Shaw RJ, et al. Among authors: risk jm. Nucleic Acids Res. 2006 Jun 28;34(11):e78. doi: 10.1093/nar/gkl424. Nucleic Acids Res. 2006. PMID: 16807314 Free PMC article.

5

Re: Powers JM. p53-Mediated apoptosis, neuroglobin overexpression, and globin deposits in a patient with hereditary ferritinopathy. J Neuropathol Exp Neurol 2006;65:716-21.

McRonald FE, Shaw RJ, Omar M, Risk JM. McRonald FE, et al. Among authors: risk jm. J Neuropathol Exp Neurol. 2006 Sep;65(9):931; author reply 931-2. doi: 10.1097/01.jnen.0000240240.47291.d3. J Neuropathol Exp Neurol. 2006. PMID: 16957587 No abstract available.

6

CpG island methylation phenotype (CIMP) in oral cancer: associated with a marked inflammatory response and less aggressive tumour biology.

Shaw RJ, Hall GL, Lowe D, Bowers NL, Liloglou T, Field JK, Woolgar JA, Risk JM. Shaw RJ, et al. Among authors: risk jm. Oral Oncol. 2007 Oct;43(9):878-86. doi: 10.1016/j.oraloncology.2006.10.006. Epub 2007 Jan 25. Oral Oncol. 2007. PMID: 17257884

7

Quantitative methylation analysis of resection margins and lymph nodes in oral squamous cell carcinoma.

Shaw RJ, Hall GL, Woolgar JA, Lowe D, Rogers SN, Field JK, Liloglou T, Risk JM. Shaw RJ, et al. Among authors: risk jm. Br J Oral Maxillofac Surg. 2007 Dec;45(8):617-22. doi: 10.1016/j.bjoms.2007.04.015. Epub 2007 Jun 7. Br J Oral Maxillofac Surg. 2007. PMID: 17559992

8

Tissue banking in head and neck cancer.

Hall GL, Kademani D, Risk JM, Shaw RJ. Hall GL, et al. Among authors: risk jm. Oral Oncol. 2008 Feb;44(2):109-15. doi: 10.1016/j.oraloncology.2007.08.002. Epub 2007 Oct 23. Oral Oncol. 2008. PMID: 17936672 Review.

9

The role of pyrosequencing in head and neck cancer epigenetics: correlation of quantitative methylation data with gene expression.

Shaw RJ, Hall GL, Lowe D, Liloglou T, Field JK, Sloan P, Risk JM. Shaw RJ, et al. Among authors: risk jm. Arch Otolaryngol Head Neck Surg. 2008 Mar;134(3):251-6. doi: 10.1001/archoto.2007.50. Arch Otolaryngol Head Neck Surg. 2008. PMID: 18347248

10

p16 Promoter methylation is a potential predictor of malignant transformation in oral epithelial dysplasia.

Hall GL, Shaw RJ, Field EA, Rogers SN, Sutton DN, Woolgar JA, Lowe D, Liloglou T, Field JK, Risk JM. Hall GL, et al. Among authors: risk jm. Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2174-9. doi: 10.1158/1055-9965.EPI-07-2867. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18708411 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

94 results

Search Page